Key Takeaways
- • California Attorney General Rob Bonta filed an unsolicited amicus brief in *Art Center Holdings, Inc. v. WCE CA ART, LLC* arguing that PC-MSO (professional corporation–management services organization) structures violate the state's corporate practice of medicine (CPOM) prohibition, even when contractual control rights are never exercised.
- • The AG's challenge targets continuity agreements, stock transfer agreements, and assignable option agreements that grant MSOs unilateral rights to replace physician-owners or transfer equity to successor physicians—a foundational structure widely used by venture-backed and private equity-backed digital health and healthcare platform companies in California.
- • The trial court previously granted a receivership to restore physician control at WCE, a private equity-backed MSO, finding its Continuity Agreement constituted unlicensed corporate practice of medicine; the Court of Appeal case remains pending with the AG's amicus filing supporting the trial court's CPOM interpretation.
- • California's existing SB-351 and AB-1415 laws already govern MSO and private equity influence in virtual care and digital health sectors, creating compounding regulatory pressure on the PC-MSO model that has protected venture capital and PE investments through share transfer restrictions and physician-control safeguards.
- • Healthcare companies relying on PC-MSO structures in California must immediately audit continuity planning agreements, management services contracts, and physician shareholder transfer provisions for CPOM compliance exposure and consider structural alternatives or contractual modifications to address evolving AG enforcement signals.
Summary
California Attorney General Rob Bonta escalated regulatory scrutiny of a foundational business model underlying much of the state's venture-backed and private equity-backed healthcare infrastructure by filing an amicus brief that challenges the legitimacy of PC-MSO structures on corporate practice of medicine grounds. The filing in *Art Center Holdings, Inc. v. WCE CA ART, LLC*—a case pending before the California appellate court—argues that professional corporation–management services organization arrangements, in which the MSO holds contractual rights to replace physician-owners or transfer professional corporation equity to successor physicians, violate California's prohibition on corporate practice of medicine regardless of whether those control rights are ever exercised.
The underlying dispute originated when a trial court granted a receivership restoring control to physicians at WCE, a private equity-backed MSO, after finding that WCE's Continuity Agreement—which permitted the MSO to terminate the physician-owner and reassign PC equity to an MSO-selected replacement—constituted unlicensed corporate practice of medicine. The AG's amicus brief endorses this trial court analysis, signaling the state's top law enforcement official views the contractual architecture of these arrangements, not merely their operational implementation, as the legal problem.
The PC-MSO structure has been central to venture capital and private equity investment strategies in digital health, telehealth, and healthcare services companies operating in California. These arrangements typically use continuity agreements, stock transfer restrictions, assignable option agreements, and related contractual mechanisms to give institutional investors protective control over physician shareholders while maintaining the appearance of physician professional control required under CPOM law. The AG's challenge directly threatens this contractual foundation for continuity planning and investor protection across the venture-backed and private equity-backed healthcare ecosystem in the state.
This enforcement escalation arrives alongside California's recently enacted SB-351 and AB-1415, which already introduced new regulatory restrictions on MSO and private equity influence in virtual care and digital health companies. Companies operating PC-MSO structures in California should immediately review continuity agreements, management services contracts, stock transfer provisions, and related physician-shareholder agreements for potential CPOM exposure. Legal and compliance teams face pressure to either restructure these arrangements, modify contractual language to eliminate unilateral MSO control rights, or prepare for litigation exposure as the appellate court decision unfolds.
The underlying dispute originated when a trial court granted a receivership restoring control to physicians at WCE, a private equity-backed MSO, after finding that WCE's Continuity Agreement—which permitted the MSO to terminate the physician-owner and reassign PC equity to an MSO-selected replacement—constituted unlicensed corporate practice of medicine. The AG's amicus brief endorses this trial court analysis, signaling the state's top law enforcement official views the contractual architecture of these arrangements, not merely their operational implementation, as the legal problem.
The PC-MSO structure has been central to venture capital and private equity investment strategies in digital health, telehealth, and healthcare services companies operating in California. These arrangements typically use continuity agreements, stock transfer restrictions, assignable option agreements, and related contractual mechanisms to give institutional investors protective control over physician shareholders while maintaining the appearance of physician professional control required under CPOM law. The AG's challenge directly threatens this contractual foundation for continuity planning and investor protection across the venture-backed and private equity-backed healthcare ecosystem in the state.
This enforcement escalation arrives alongside California's recently enacted SB-351 and AB-1415, which already introduced new regulatory restrictions on MSO and private equity influence in virtual care and digital health companies. Companies operating PC-MSO structures in California should immediately review continuity agreements, management services contracts, stock transfer provisions, and related physician-shareholder agreements for potential CPOM exposure. Legal and compliance teams face pressure to either restructure these arrangements, modify contractual language to eliminate unilateral MSO control rights, or prepare for litigation exposure as the appellate court decision unfolds.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.